Jian Li

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 529 citations

Medicine, Oncology, Pharmacology +10

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)

Li Chen, Hongming Zhu, Yan Li et al. · Proceedings of the National Academy of Sciences · 2021 · 62 citations · Full text

Medicine, Hematology, Oncology +12

Serum and Urinary Metabonomic Study of Human Osteosarcoma

Zhiyu Zhang, Yunping Qiu, Yingqi Hua et al. · Journal of Proteome Research · 2010 · 48 citations

Medicine, Biochemistry, Oncology +17

Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma

Chao Wu, Guoqing Zhang, Lin Wang et al. · Oncogene · 2024 · 28 citations · Full text

Medicine, Immunology, Oncology +14

Co-Channel Interference Modeling in Cognitive Wireless Networks

Jian Li, Shenghong Li, Feng Zhao et al. · IEEE Transactions on Communications · 2014 · 25 citations · Full text

Engineering, Electrical Engineering, Computer Networks +16